Literature DB >> 22584901

Epidemiologic and genetic characteristics of alopecia areata (part 2).

Abdullateef A Alzolibani1, Shadi Zari, Ahmed A Ahmed.   

Abstract

Alopecia areata (AA) is hypothesized to be an organ-specific autoimmune disease mediated by T cells to the hair follicles. Despite the fact that most cases of AA are sporadic, there is an accumulation of evidence that AA is a complex multigenetic trait with components of inherited predisposition. In the last decade, rapid progress in molecular genetics and biotechnology has led to the identification of many candidate genes in humans that confer susceptibility to AA. The first part of this review focused on the association of HLA genes with the disease. The second part reviews non-HLA and other genes associated with AA, including the autoimmune regulator (AIRE) gene. Recently, the lymphoid-specific protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene was found to be an additional immunoregulatory gene associated with AA. In addition, alleles of genes coding for cytokines and their receptors, such as the interleukin-1 receptor antagonist (IL1RN) and chemokines (MCP-1), have also been associated with AA. Some studies have hypothesized that filaggrin gene mutations (FLG) may also play a role in AA, particularly in patients with comorbid atopic disease. MX1 is another new candidate gene in AA. Thus, this second part of the review completes the overview of current knowledge about the molecular genetics of AA begun in the first part.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584901

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  9 in total

1.  Association between interleukin 18 polymorphisms and alopecia areata in Koreans.

Authors:  Su Kang Kim; Hae Jeong Park; Joo-Ho Chung; Jong Woo Kim; Hosik Seok; Bark-Lynn Lew; Woo-Young Sim
Journal:  J Interferon Cytokine Res       Date:  2014-01-21       Impact factor: 2.607

2.  Alternaria scalp infection in a patient with alopecia areata. Coexistence or causative relationship?

Authors:  Lidia Rudnicka; Malgorzata Lukomska
Journal:  J Dermatol Case Rep       Date:  2012-12-31

3.  Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association.

Authors:  Suad Alfadhli; Arti Nanda
Journal:  Clin Exp Med       Date:  2013-04-13       Impact factor: 3.984

4.  Association between PTPN22 C1858T polymorphism and alopecia areata risk.

Authors:  Mauricio Salinas-Santander; Celia Sánchez-Domínguez; Cristina Cantú-Salinas; Hugo Gonzalez-Cárdenas; Ana Cecilia Cepeda-Nieto; Ricardo M Cerda-Flores; Rocío Ortiz-López; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2015-09-04       Impact factor: 2.447

Review 5.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

6.  Alopecia Areata-Quality of Life Index Questionnaire (Reliability and Validity of the Persian Version) in Comparison to Dermatology Life Quality Index.

Authors:  Maryam Nasimi; Narges Ghandi; Leyla Torabzade; Safoura Shakoei
Journal:  Int J Trichology       Date:  2020-11-03

7.  Genetic Association between Interleukin Genes and Alopecia Areata in Jordanian Patients.

Authors:  Laith N Al Eitan; Mansour A Alghamdi; Rawan O Al Momani; Hanan A Aljamal; Bijo Elsy; Heitham M Mohammed; Asim M Abdalla
Journal:  Oman Med J       Date:  2022-09-30

8.  Genetic prediction of male pattern baldness.

Authors:  Saskia P Hagenaars; W David Hill; Sarah E Harris; Stuart J Ritchie; Gail Davies; David C Liewald; Catharine R Gale; David J Porteous; Ian J Deary; Riccardo E Marioni
Journal:  PLoS Genet       Date:  2017-02-14       Impact factor: 5.917

9.  Quality of life in mild and severe alopecia areata patients.

Authors:  Robabeh Abedini; Zahra Hallaji; Vahideh Lajevardi; Maryam Nasimi; Mona Karimi Khaledi; Hamid Reza Tohidinik
Journal:  Int J Womens Dermatol       Date:  2017-09-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.